Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
ANIK on Nasdaq
Shares outstanding
14,423,417
Price per share
$9.61
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
12,175,612
Total reported value
$117,003,356
% of total 13F portfolios
0%
Share change
-23,640
Value change
-$227,227
Number of holders
123
Price from insider filings
$9.61
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Caligan Partners LP 10% 0% $13,791,743 1,435,130 0% Caligan Partners LP 23 Jan 2026
BlackRock, Inc. 6.8% -35% $14,147,616 -$8,737,671 963,078 -38% BlackRock, Inc. 31 Mar 2025
BlackRock Portfolio Management LLC 5.5% $7,454,957 793,359 BlackRock Portfolio Management LLC 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 4.5% $9,656,545 657,355 Dimensional Fund Advisors LP 31 Dec 2024
Trigran Investments, Inc. 1.2% -91% $1,618,745 -$13,965,184 168,400 -90% Trigran Investments, Inc. 31 Dec 2025

As of 31 Dec 2025, 123 institutional investors reported holding 12,175,612 shares of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK). This represents 84% of the company’s total 14,423,417 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) together control 70% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 11% 1,654,537 -5% 0% $15,900,102
Caligan Partners LP 10% 1,435,130 0% 1.3% $13,791,599
VANGUARD GROUP INC 5.4% 779,165 -0.19% 0% $7,487,776
MORGAN STANLEY 5.4% 772,230 +96% 0% $7,421,132
ACADIAN ASSET MANAGEMENT LLC 4.2% 606,544 -4.1% 0.01% $5,821,000
BOOTHBAY FUND MANAGEMENT, LLC 3.7% 534,507 -0.95% 0.14% $5,136,612
RENAISSANCE TECHNOLOGIES LLC 3.6% 515,717 -3.2% 0.01% $4,956,040
CAPITAL MANAGEMENT CORP /VA 3.5% 500,465 -9.2% 0.79% $4,809,464
DIMENSIONAL FUND ADVISORS LP 3.4% 494,319 -18% 0% $4,750,348
STATE STREET CORP 2.3% 336,543 +4.1% 0% $3,234,178
GEODE CAPITAL MANAGEMENT, LLC 2.3% 325,522 -3% 0% $3,129,235
D. E. Shaw & Co., Inc. 2.1% 297,979 +70% 0% $2,863,578
TWO SIGMA INVESTMENTS, LP 1.6% 233,808 +193% 0% $2,246,895
JACOBS LEVY EQUITY MANAGEMENT, INC 1.4% 195,585 +78% 0.01% $1,879,572
Trigran Investments, Inc. 1.2% 168,400 -90% 0.32% $1,618,324
GOLDMAN SACHS GROUP INC 1.1% 164,926 +154% 0% $1,584,939
JANE STREET GROUP, LLC 0.93% 134,768 +171% 0% $1,295,120
TWO SIGMA ADVISERS, LP 0.88% 126,483 +243% 0% $1,215,502
GSA CAPITAL PARTNERS LLP 0.85% 122,062 +192% 0.1% $1,173,000
ENVESTNET ASSET MANAGEMENT INC 0.82% 117,896 -9.9% 0% $1,132,981
NORTHERN TRUST CORP 0.77% 111,709 -6.2% 0% $1,073,523
Trexquant Investment LP 0.74% 107,307 +140% 0.01% $1,031,220
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.74% 106,297 +2.3% 0% $1,021,514
Quantinno Capital Management LP 0.7% 101,549 +73% 0% $975,886
AMERICAN CENTURY COMPANIES INC 0.7% 100,321 +73% 0% $964,085

Institutional Holders of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 12,175,612 $117,003,356 -$227,227 $9.61 123
2025 Q3 12,231,336 $114,982,408 -$5,970,888 $9.40 114
2025 Q2 12,685,136 $134,203,655 -$1,529,085 $10.58 101
2025 Q1 12,677,819 $190,700,837 +$2,180,082 $15.03 107
2024 Q4 12,529,691 $206,235,517 -$14,093,626 $16.46 108
2024 Q3 13,093,708 $323,524,735 -$7,569,530 $24.70 121
2024 Q2 13,238,350 $335,327,792 -$3,265,667 $25.33 113
2024 Q1 13,404,303 $340,492,164 +$4,319,363 $25.40 119
2023 Q4 13,250,118 $300,245,422 +$6,673,700 $22.66 116
2023 Q3 13,003,869 $242,256,970 -$5,557,577 $18.63 116
2023 Q2 13,100,461 $340,372,426 +$436,229 $25.98 116
2023 Q1 13,079,037 $375,621,420 -$1,049,447 $28.72 118
2022 Q4 13,106,170 $387,952,547 -$23,669,010 $29.60 123
2022 Q3 13,466,221 $320,512,893 -$1,527,070 $23.80 114
2022 Q2 13,537,892 $302,166,866 -$732,634 $22.32 118
2022 Q1 13,595,480 $341,424,225 +$996,762 $25.11 114
2021 Q4 13,487,182 $483,258,995 +$10,255,331 $35.83 125
2021 Q3 13,151,662 $559,519,170 -$490,889 $42.56 127
2021 Q2 13,141,807 $568,895,445 -$4,270,965 $43.29 133
2021 Q1 13,310,684 $543,030,178 -$15,429,177 $40.79 144
2020 Q4 13,538,757 $612,639,033 +$244,003 $45.26 156
2020 Q3 13,592,200 $481,004,726 -$8,432,726 $35.39 153
2020 Q2 13,813,202 $520,292,852 +$34,612,076 $37.73 155
2020 Q1 13,000,312 $375,884,789 -$23,630,047 $28.91 160
2019 Q4 13,454,848 $697,513,936 -$12,549,474 $51.85 188
2019 Q3 13,671,640 $750,377,749 -$18,168,917 $54.89 191
2019 Q2 14,024,589 $569,641,989 +$37,425,161 $40.62 164
2019 Q1 13,319,121 $402,798,234 +$13,754,863 $30.24 152
2018 Q4 12,765,105 $429,002,609 -$13,458,065 $33.61 156
2018 Q3 13,139,092 $554,138,864 -$31,421,390 $42.18 153
2018 Q2 13,943,042 $446,152,896 +$47,549,513 $32.00 163
2018 Q1 12,380,690 $615,555,237 +$15,254,180 $49.72 163
2017 Q4 12,417,396 $669,502,564 -$1,448,565 $53.91 165
2017 Q3 12,404,517 $719,433,944 +$3,285,099 $58.00 163
2017 Q2 12,374,607 $610,498,457 +$26,979,854 $49.34 154
2017 Q1 11,852,436 $514,912,867 +$107,801,621 $43.44 152
2016 Q4 10,997,247 $538,411,707 -$2,604,321 $48.96 152
2016 Q3 11,084,615 $530,426,792 -$20,700,941 $47.85 159
2016 Q2 11,499,663 $616,813,180 -$31,454,369 $53.65 159
2016 Q1 12,121,173 $542,270,562 -$11,877,450 $44.72 160
2015 Q4 12,415,909 $473,859,149 -$1,414,918 $38.16 149
2015 Q3 12,475,677 $397,091,901 +$11,089,244 $31.83 135
2015 Q2 12,143,231 $401,082,257 -$15,149,040 $33.03 136
2015 Q1 12,274,379 $505,215,345 +$17,599,542 $41.17 159
2014 Q4 11,859,338 $483,081,891 +$36,845,748 $40.74 159
2014 Q3 11,043,556 $404,914,011 +$34,112,722 $36.66 150
2014 Q2 9,987,532 $462,796,042 -$6,557,083 $46.33 160
2014 Q1 10,153,818 $417,235,325 +$54,137,543 $41.10 152